INSIGHTS ON DRUG DEVELOPMENT

• A Study To Assess Organoid Size And Cell Count From 3D Image Analysis

  Recent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.

• Partners In Progress: Shaping The Future Of Childhood Cancer Treatment

  In this panel, Stephanie Heathman, Business Development Lead for the Opie Jones Foundation, discusses the Foundation’s mission and inspiration.

• Are You Keeping Pace With Oligo Synthesis Optimization?

  The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.

• Viral Gene Therapy: Reducing Costs To Improve Patient Access

  Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.

• Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development

  6/19/2025

  Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.

• Predictive Validity: The Key To Improving The Drug Development Process

  2/13/2024

  The drug development industry recognizes the importance of predictive validity, but Jack Scannell, the author of Eroom’s law, and a team of experts argue it is far more crucial than most believe it is.

• Your Guide To Precise And Robust Separation Methods

  11/12/2025

  Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.

• The Importance Of Reliable Mixing In ITC Experiments

  5/1/2025

  Explore how Isothermal Titration Calorimetry (ITC) precisely analyzes molecular interactions, which provides crucial thermodynamic data to understand physiological processes and develop new therapeutic strategies.

• Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions

  11/20/2025

  Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.